Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

More documents

Recommendations

Info

Dr David Wilkinson BMBS, Dip RACOG, DA (UK), FANZCA Director, Hyperbaric Medicine Unit Dept of Anaesthesia & Intensive Care, Royal Adelaide Hospital Staff Specialist Anaesthetist, Womens & Childrens Hospital, SA Dr Robert Wong B Sc. MBBS, FFARACS, DipDHM, FANZCA, Director of Hyperbaric Medicine, Fremantle Hospital, WA Anaesthetist, Royal Perth Hospital, WA co-opted member nominated by the Australian and New Zealand College of Anaesthetists 96 Hyperbaric oxygen therapy
Appendix C Studies included in this review Thermal burns First Author and Year of Publication Brannen 1997 38 Niezgoda 1997 39 Hammarlund 1991 40 Cianci 1990 41 Gorman 1988 42 Niu 1987 43 Waisbren 1982 44 Hart 1974 45 NHMRC Level Study Design Location Dates of Enrolment Size II RCT USA ? ‡ 125 ? Characteristics of Study Population † Age (years) Mean (SD) II RCT USA ? 12 ? 7:5 III-2 Comparative study Sweden ? 9 26 (24-29) § 9:0 III-2 Comparative study USA III-3 Comparative study with historical controls Australia Jan 1982 to Jul 1987 T=Jul 1986 to Jun 1988 C=Jan 1983 to Jun 1986 Sex Ratio (M:F) I=50:12 C=44:19 Hyperbaric oxygen therapy 97 21 180 III-2 Comparative study Taiwan After 1981 875 III-2 Comparative study USA ? 72 II RCT USA Nov 1972 to Jan 1974 16 I=28 (9) C=29 (8.3) I=34.2 (14.9) C=38.6 (17.2) I=27 (2-82) § C=26 (7/12-80) I=35.2 (15.0) # C=35.6 (14.8) I=21.62 C=21.31 * Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard deviation. † Information is given for intervention and comparison groups, if available. Otherwise, total study population values are stated. ‡ Unstated, unclear, or unknown. § Median of total population. Figures in parentheses are ranges. # Figures in parentheses are assumed to be standard deviations. Authors did not provide enough information for a definite conclusion. Diabetic wounds First Author and Year of Publication Faglia 1998 48 Zamboni 1997 50 Faglia 1996 47 Doctor 1992 49 Baroni 1987 46 NHMRC Level Study Design Location III-2 Comparative study Italy III-2 Comparative study USA ? ‡ II RCT Italy II RCT India III-2 Comparative study Italy Dates of Enrolment 1990 to 1993 ? ? ? ? 14:2 Characteristics of Study Population † Siz e 11 5 10 Aug 1993 to Aug ’95 68 2 years. No specific dates. 30 Jan 1982 to Dec 1984 28 Age (years) Mean (SD) Sex Ratio (M:F) 63.4 (9.9) 84:31 I=63.6 (8.9) C=53.8 (7.8) I=61.7 (10.4) C=65.6 (9.1) I=56.2 (45-70) § C=59.8 (48-70) I=57.7 (7.4) C=59.4 (7.6) I=4:1 C=4:1 I=27:8 C=21:12 I=3:1 C=2:1 I=11:7 C=6:4 * Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard deviation. † Information is given for treatment and control groups, if available. Otherwise, total study population values are stated. ‡ Unstated, unclear, or unknown. § Figures in parentheses are ranges.
Page 1 and 2:
Hyperbaric Oxygen Therapy November
Page 3 and 4:
Contents Executive summary.........
Page 5 and 6:
Tables Table 1 Measures of disease
Page 7 and 8:
Table 45 Functional neurologic scor
Page 9 and 10:
Figures Figure 1. Outline of search
Page 11 and 12:
Effectiveness Published guidelines
Page 13 and 14:
evidence that exposure to HBO may b
Page 15 and 16:
No available evidence No evidence w
Page 17 and 18:
Introduction The Medicare Services
Page 19 and 20:
Multiplace chambers can accommodate
Page 21 and 22:
Marketing status of the device The
Page 23 and 24:
Table 3 1998 - 1999 self-reported d
Page 25 and 26:
Table 6 retrieval. Indication-speci
Page 27 and 28:
Phase of Search Initial Search Ful
Page 29 and 30:
Conduct of meta-analysis When the d
Page 31 and 32:
early as 1995. The guidelines - kno
Page 33 and 34:
Table 10 Minimum staff qualificatio
Page 35 and 36:
Is it effective? The review assesse
Page 37 and 38:
Table 14 Patient criteria of includ
Page 39 and 40:
offered ample details. The remainin
Page 41 and 42:
characteristics compared to the tre
Page 43 and 44:
Assessment of heterogeneity All the
Page 45 and 46:
Odds ratio 10 1 0.1 0.01 A sensitiv
Page 47 and 48:
Wound healing Two of the five ident
Page 49 and 50:
Studies of necrotising soft tissue
Page 51 and 52:
Summary Table 25 Survival in patien
Page 53 and 54:
Table 29 Therapeutic protocols used
Page 55 and 56:
Osteomyelitis The study by Esterhai
Page 57 and 58:
Summary The HBO group showed a stat
Page 59 and 60:
Summary These results are difficult
Page 61 and 62: outcomes or that decreased the risk
Page 63 and 64: Anderson et al 80 recruited non-pre
Page 65 and 66: Summary The collected evidence exam
Page 67 and 68: Table 46 Major outcomes following t
Page 69 and 70: Table 50 Therapeutic protocols used
Page 71 and 72: Table 53 Patient criteria of includ
Page 73 and 74: Thirty-seven subjects (comparison g
Page 75 and 76: whose hearing loss was not secondar
Page 77 and 78: tinnitus (6 versus 3 subjects). Non
Page 79 and 80: assume that all participants knew o
Page 83 and 84: Table 65 Descriptive characteristic
Page 87 and 88: These contrasted with the conclusio
Page 89 and 90: Table 73 Patient criteria of includ
Page 91 and 92: Summary There are conflicting resul
Page 93 and 94: Summary separate and previously-stu
Page 95 and 96: need to insulate patients from outs
Page 97 and 98: Reactive effects A reactive effect
Page 99 and 100: Cost of major amputation The hospit
Page 101 and 102: Sensitivity analysis Table 79 shows
Page 103 and 104: Table 80 Estimation of incremental
Page 105 and 106: Sensitivity analysis Table 83 shows
Page 107 and 108: Conclusions Safety Potential risks
Page 109 and 110: Recommendations MSAC recommended th
Page 111: Appendix B Supporting committee Sup
Page 115 and 116: Necrotising soft tissue infections:
Page 117 and 118: Soft tissue injuries: crush injurie
Page 119 and 120: Cancer: cervix First Author and Yea
Page 121 and 122: Appendix D Studies excluded in this
Page 123 and 124: 2. Shandling AH, Ellestad MH, Hart
Page 125 and 126: 5. Woo TCS, Joseph D, Oxer H. Hyper
Page 127 and 128: 22. Kunkler PB, Boulis-Wassif S, Sh
Page 129 and 130: 45. Wiernik G, Perrins D. The radio
Page 131 and 132: Appendix E Calculation of monoplace
Page 133 and 134: Hence, the total operating costs of
Page 135 and 136: Appendix G Reviews received from ot
Page 137 and 138: Sechrist Industries -- Hyperbaric O
Page 139 and 140: References 1. Hampson N. Hyperbaric
Page 141 and 142: 31. L'Abbe K, Detsky A, O'Rourke K.
Page 143 and 144: 61. Perrins DJ. Influence of hyperb
Page 145 and 146: 89. DiSabato F, Giacovazzo M, Crist
Page 147: 117.Plenk HP. Hyperbaric radiation
show all

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?